Wockhardt Limited
SBI Life Insurance added over 0.64% of Wockhardt and now holds 1.64%, or 26,72,967 shares.
A global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals, and topicals for diverse therapeutic applications. Wockhardt operates across multiple segments, serving domestic and international markets with a comprehensive product portfolio spanning conventional pharmaceuticals and advanced biopharmaceutical solutions. The company distinguishes itself through vertically integrated operations and a focus on both established and emerging therapeutic areas.
Joint venture between State Bank of India and BNP Paribas Cardif. Manages over Rs 4.7 lakh crore in total AUM with the flagship SBI Life Equity Fund alone holding over Rs 77,000 crore. One of India's largest private life insurers by AUM, with a multi-cap equity book deployed across ULIP and participating funds.